X-Biomedical
Wayne, US · Founded 2017 · Delaware corporation
Founders & leadership
GN
Godfrey NazarethPresident, CEO, Secretary & Treasurer
MM
Matthew MalteseNamed on SEC filing
KK
Karen Keating MaraGeneral Counsel & Assistant Secretary
Reported raises · per SEC filings
Form D private placements$425K disclosed across 1 round · 2018
▶$425KraisedJul 2018 · 4 investors · BiotechnologyRule 506(b)
▶$425KraisedJul 2018 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew MalteseDirector
- Karen Keating MaraExecutive Officer
- Godfrey NazarethExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $425K
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $293.5K |
| Department of Transportation | Phase I | 2023 | $146.9K |
| U.S. Air ForceAir Force | Phase I | 2019 | $48.8K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- How much funding has X-Biomedical raised?
- X-Biomedical has disclosed $425K raised across 1 round.
- Where is X-Biomedical headquartered?
- X-Biomedical is headquartered in Wayne, US.